首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >TREATMENT PATTERNS, BIOMARKER TESTING (BMX) PRACTICES AND HEALTHCARE RESOURCE USE (HCRU) IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN TAIWAN

【24h】

TREATMENT PATTERNS, BIOMARKER TESTING (BMX) PRACTICES AND HEALTHCARE RESOURCE USE (HCRU) IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN TAIWAN

机译：台湾地区非小细胞肺癌晚期患者的治疗模式，生物标志物测试（BMX）做法和医疗资源使用（HCRU）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共2页
作者
Kothari S.; Arunachalam A.; Chen C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. TREATMENT PATTERNS, BIOMARKER TESTING (BMX) PRACTICES AND HEALTHCARE RESOURCE USE (HCRU) IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN TAIWAN [J] . Kothari S., Arunachalam A., Chen C. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：台湾地区非小细胞肺癌晚期患者的治疗模式，生物标志物测试（BMX）做法和医疗资源使用（HCRU）
2. P1.06-021 Treatment Patterns and Healthcare Resource Use from a Retrospective Cohort of Japanese Patients with Advanced Non-Small Cell Lung Cancer [J] . Terufumi Kato, Kiyoshi Mori, Koichi Minato, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.06-021从日本晚期非小细胞肺癌的日本患者叙事队列的治疗模式和医疗资源使用
3. P1.06-021 Treatment Patterns and Healthcare Resource Use from a Retrospective Cohort of Japanese Patients with Advanced Non-Small Cell Lung Cancer [J] . Terufumi Kato, Kiyoshi Mori, Koichi Minato, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.06-021从日本晚期非小细胞肺癌的日本患者叙事队列的治疗模式和医疗资源使用
4. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab [O] . Edoardo Lenci, Luca Cantini, Federica Pecci, 2021

机译：古斯塔韦鲁西免疫（Grim）-core变异是用第一线彭布罗卢比的晚期非小细胞肺癌（NSCLC）患者的早期治疗生物标志物

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号